IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients

References

• Stone JH, Zen Y, Deshpande V IgG4-related disease. N Engl J Med 2012; 366:539–51.
   PubMed Web of Science ®Google Scholar
• Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344:732–8.
   PubMed Web of Science ®Google Scholar
• Khosroshahi A, Carruthers MN, Stone JH, Shinagare S, Sainani N, Hasserjian RP, et al. Rethinking Ormond’s disease: ‘idiopathic’ retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore) 2013; 92:82–91.
   PubMed Web of Science ®Google Scholar
• Lu LX, Della-Torre E, Stone JH, Clark SW IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. JAMA Neurol 2014; 71:785–93.
   PubMed Web of Science ®Google Scholar
• Della-Torre E, Passerini G, Furlan R, Roveri L, Chieffo R, Anzalone N, et al. Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis. J Rheumatol 2013; 40:1927–9.
   PubMed Web of Science ®Google Scholar
• Della-Torre E, Galli L, Franciotta D, Bozzolo EP, Briani C, Furlan R, et al. Diagnostic value of IgG4 indices in IgG4-related hypertrophic pachymeningitis. J Neuroimmunol 2014; 266:82–6.
   PubMed Web of Science ®Google Scholar
• Della Torre E, Bozzolo EP, Passerini G, Doglioni C, Sabbadini MG. IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis. Ann Intern Med 2012; 156:401–3.
   PubMed Web of Science ®Google Scholar
• Hamano H, Umemura T, Uehara T, Kawa S, Kiyosawa K IgG4-related sclerosing cholangitis should be included as an exclusion criterion for the diagnosis of primary sclerosing cholangitis. Am J Gastroenterol 2007; 102:691–2.
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Khosroshahi A, Jakobiec FA, Deshpande V, Hatton MP, Ritter J, et al. IgG4-related systemic disease as a cause of ‘idiopathic’ orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol 2012; 57:26–33.
   PubMed Web of Science ®Google Scholar
• Della-Torre E, Mattoo H, Mahajan VS, Deshpande V, Krause D, Song P, et al. IgG4-related midline destructive lesion. Ann Rheum Dis 2014; 73:1434–6.
   PubMed Web of Science ®Google Scholar
• Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 2015; 74:14–18.
   PubMed Web of Science ®Google Scholar
• Ngwa TN, Law R, Murray D, Chari ST Serum immunoglobulin G4 level is a poor predictor of immunoglobulin G4-related disease. Pancreas 2014; 43:704–7.
   PubMed Web of Science ®Google Scholar
• Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012; 25:1181–92.
   PubMed Web of Science ®Google Scholar
• Kamisawa T, Okazaki K, Kawa S, Shimosegawa T, Tanaka M Japanese consensus guidelines for management of autoimmune pancreatitis. III. Treatment and prognosis of AIP. J Gastroenterol 2010; 45:471–7.
   PubMed Web of Science ®Google Scholar
• Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008; 134:706–15.
   PubMed Web of Science ®Google Scholar
• Hart PA, Kamisawa T, Brugge WR, Chung JB, Culver EL, Czakó L, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013; 62:1771–6.
   PubMed Web of Science ®Google Scholar
• Khosroshahi A, Stone JH Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol 2011; 23:67–71.
   PubMed Web of Science ®Google Scholar
• Della-Torre E, Campochiaro C, Bozzolo EP, Dagna L, Scotti R, Nicoletti R, et al. Methotrexate for maintenance of remission in IgG4-related disease. Rheumatology (Oxford). Published online: 2 July 2015. doi:10.1093/rheumatology/kev244
   Google Scholar
• Khosroshahi A, Bloch DB, Deshpande V, Stone JH Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010; 62:1755–62.
   PubMed Web of Science ®Google Scholar
• Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis 2015; 74:1171–7.
   PubMed Web of Science ®Google Scholar
• Della-Torre E, Feeney E, Deshpande V, Mattoo H, Mahajan V, Kulikova M, et al. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. Published online: 20 August 2014. doi:10.1136/annrheumdis-2014-205799.
   Web of Science ®Google Scholar
• Huggett MT, Culver EL, Kumar M, Hurst JM, Rodriguez-Justo M, Chapman MH, et al. Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol 2014; 109:1675–83.
   PubMed Web of Science ®Google Scholar
• Ebbo M, Daniel L, Pavic M, Sève P, Hamidou M, Andres E, et al. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine (Baltimore) 2012; 91:49–56.
   PubMed Web of Science ®Google Scholar
• Frulloni L, Lunardi C, Simone R, Dolcino M, Scattolini C, Falconi M, et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 2009; 361: 2135–42.
   PubMed Web of Science ®Google Scholar
• Caso F, Fiocco U, Costa L, Sfriso P, Punzi L, Doria A Successful use of rituximab in a young patient with immunoglobulin G4-related disease and refractory scleritis. Joint Bone Spine 2014; 81:190–2.
   PubMed Web of Science ®Google Scholar
• Maida M, Macaluso FS, Cabibbo G, Lo Re G, Alessi N Progressive multi-organ expression of immunoglobulin G4-related disease: A case report. World J Hepatol 2013; 5:336–9.
   PubMedGoogle Scholar
• Marando A, D’Ambrosio G, Catanzaro F, La Rosa S, Sessa F IgG4-related disease of the ureter: report of two cases and review of the literature. Virchows Arch 2013; 462:673–8.
   PubMed Web of Science ®Google Scholar
• Lombardi C, Belli D, Facchetti F, Passalacqua G IgG4: not only for allergists. Int J Immunopathol Pharmacol 2013; 26:571–4.
   PubMed Web of Science ®Google Scholar
• Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012; 22:21–30.
   PubMed Web of Science ®Google Scholar
• Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011; 40:352–8.
   PubMed Web of Science ®Google Scholar
• Carruthers MN, Stone JH, Deshpande V, Khosroshahi A. Development of an IgG4-RD responder index. Int J Rheumatol 2012; 2012:259408.
   PubMedGoogle Scholar
• Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56:813–24.
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Mattoo H, Carruthers M, Mahajan VS, Della Torre E, Lee H, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis 2015; 74:190–5.
   PubMed Web of Science ®Google Scholar
• Della Torre E, Mattoo H, Mahajan VS, Carruthers M, Pillai S, Stone JH Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy 2014; 69:269–72.
   PubMed Web of Science ®Google Scholar
• Dahl R, Andersen PS, Chivato T, Valovirta E, de Monchy J National prevalence of respiratory allergic disorders. Respir Med 2004; 98:398–403.
   PubMed Web of Science ®Google Scholar
• Moriyama M, Furukawa S, Kawano S, Goto Y, Kiyoshima T, Tanaka A, et al. The diagnostic utility of biopsies from the submandibular and labial salivary glands in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz’s disease. Int J Oral Maxillofac Surg 2014; 43:1276–81.
   PubMed Web of Science ®Google Scholar
• Hiepe F, Dörner T, Hauser AE, Hoyer BF, Mei H, Radbruch A Long-lived autoreactive plasma cells drive persistent autoimmune inflammation. Nat Rev Rheumatol 2011; 7:170–8.
   PubMed Web of Science ®Google Scholar
• De Luna G, Terrier B, Kaminsky P, Le Quellec A, Maurier F, Solans R, et al. Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes. Rheumatology (Oxford) 2015; 54: 424–32.
   PubMed Web of Science ®Google Scholar